Auto saved by Logseq

pages/STOP2030___Annual Meeting___2024___Session 2.md

@@ -9,4 +9,5 @@
 - Month 11: strongyloides. we're doing serology for it.
 - for the CRF: why are we not using directly tablets for it.  We're using paper: it was a matter of cost on one site, the CFR is rather short. Maybe its good a idea to put it on paper and transfer it to the CRF.
 - Stella: In terms of regulatory, if Redcap has trazability entonces sí podemos, pero si no no. Is it possible to sign or countersign. That is one of the things you keep hearing.
-- EMA has very strict requirements about software for Clinical trials.
+- EMA has very strict requirements about software for Clinical trials.
+- We can have source documents that are electronic or not, mainly